deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT03475342

World Maternal Antifibrinolytic Trial_2 (WOMAN-2)

Tranexamic Acid for the Prevention of Postpartum Bleeding in Women With Anaemia: an International, Randomised, Double-blind, Placebo Controlled Trial.

Sponsor: Bill and Melinda Gates Foundation

Conditions Intrapartum - Moderate and Severe Anaemia
Interventions Placebo Tranexamic Acid
Updated 17 times since 2018 Last updated: Jan 5, 2024 Started: Aug 24, 2019 Primary completion: Sep 20, 2023 Completion: Oct 29, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Intrapartum - Moderate and Severe Anaemia, this trial is completed. The trial is conducted by Bill and Melinda Gates Foundation and has accumulated 17 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Jan 2019 · 5 months · monthly snapshot~Jan 2019 – ~Apr 2019 · 3 months · monthly snapshot~Apr 2019 – ~Jul 2019 · 3 months · monthly snapshot~Jul 2019 – ~Mar 2020 · 8 months · monthly snapshot~Mar 2020 – ~Jan 2021 · 10 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Jun 2021 · 3 months · monthly snapshot~Jun 2021 – ~May 2022 · 11 months · monthly snapshot~May 2022 – ~Sep 2022 · 4 months · monthly snapshot~Sep 2022 – ~May 2023 · 8 months · monthly snapshot~May 2023 – ~Feb 2024 · 9 months · monthly snapshot~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

17 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Feb 2024 — Jul 2024 [monthly]

    Completed PHASE3

    Status: Recruiting → Completed

  5. May 2023 — Feb 2024 [monthly]

    Recruiting PHASE3

▶ Show 12 earlier versions

  1. Sep 2022 — May 2023 [monthly]

    Recruiting PHASE3

  2. May 2022 — Sep 2022 [monthly]

    Recruiting PHASE3

  3. Jun 2021 — May 2022 [monthly]

    Recruiting PHASE3

  4. Mar 2021 — Jun 2021 [monthly]

    Recruiting PHASE3

  5. Jan 2021 — Mar 2021 [monthly]

    Recruiting PHASE3

  6. Mar 2020 — Jan 2021 [monthly]

    Recruiting PHASE3

    Status: Not Yet Recruiting → Recruiting

  7. Jul 2019 — Mar 2020 [monthly]

    Not Yet Recruiting PHASE3

  8. Apr 2019 — Jul 2019 [monthly]

    Not Yet Recruiting PHASE3

  9. Jan 2019 — Apr 2019 [monthly]

    Not Yet Recruiting PHASE3

  10. Aug 2018 — Jan 2019 [monthly]

    Not Yet Recruiting PHASE3

  11. Jun 2018 — Aug 2018 [monthly]

    Not Yet Recruiting PHASE3

  12. Apr 2018 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bill and Melinda Gates Foundation
  • London School of Hygiene and Tropical Medicine
  • Wellcome Trust
Data source: London School of Hygiene and Tropical Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Abbottabad, Pakistan , Akure, Nigeria , Arusha, Tanzania , Bahawalpur, Pakistan , Dar es Salaam, Tanzania , Dodoma, Tanzania , Gujrat, Pakistan , Ibadan, Nigeria , Ilorin, Nigeria , Islamabad, Pakistan and 15 more locations